Autonomic influences on the heart rate have been the subject of intense research for many decades and are classically devoted to the sympathetic and parasympathetic systems. However, developments over the past few years in our knowledge of the organization of the autonomic nervous system have led to the conclusion that in addition to the classical transmitters, peptidic transmitters are clearly present and have direct or indirect actions on cardiac conduction. Neuropeptides have been found to collocate with each other or with classical transmitters, thereby increasing the variety of chemical signals that a neuron can utilize to communicate with other cells. Neuropeptides can act as neurotransmitters, neuromodulators or neurohormones. Some are produced in endocrine glands and circulate as hormones, while others are contained in cardiac myocytes, neurons, or endothelial cells in proximity to the sinoatrial node and can therefore act in a paracrine or autocrine way on the pacemaker cells to modulate heart frequency. There is evidence supporting such a role, especially for locally situated neuropeptide Y, vasoactive intestinal peptide, calcitonin gene-related peptide, substance P, angiotensin II, natriuretic peptides, endothelins and possibly many others. The role of the peptidic neurotransmitters in the conduction system should not be exaggerated. Nevertheless, neuropeptides certainly represent a new category of neurotransmitters forming a third component of the autonomic nervous system and may have complex actions with potential therapeutic implications in man. q 1998 Elsevier Science B.V.
Introduction
It is estimated that two and a half billion cardiac beats occur during a normal human life time. The rate at which these beats happen is a factor, among others, determining Ž cardiac performance. Specialized cardiomyocytes i.e.
. pacemaker cells which form the sinoatrial node are responsible for the generation and the conduction of electrical impulses to the working myocardium. It has been suggested that these conduction myocytes correspond to remnants of embryonic myocytes at the heart tube stage w x 1 . The pattern of expression of some genes displayed by pacemaker cells indicates that conduction myocytes are a distinct cardiac myocyte population and it has been prow x posed that they originate from the neuroectoderm 2 .
The control of heart rate by the sympathetic and ) Ž . Ž . Corresponding author. Tel.: q1 514 343-6506; fax: q1 514 343-2291; E-mail: lambec@ere.umontreal.ca Ž . parasympathetic classical systems is well established. However, there is accumulating evidence that peptides, especially neuropeptides, could play a role in the modulation of the activity of the sinoatrial node. A neuropeptide released locally could therefore act in three different ways: as a neurotransmitter, as a neuromodulator, or as a neurow x hormone 3 . The role of peptides in the central regulation of heart rate will not be considered in this review.
Ž . The following will be examined: 1 the coexistence between classical neurotransmitters and peptides in the autonomic nervous system and in particular in the sinoa-Ž . trial node, and their interactions; 2 the mechanisms possibly involved in the modulation of heart rate by peptides as well as the principal ones modulating heart frequency, and Ž . finally; 3 the potential role played in disease states by the peptidic modulation of heart rate.
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Coexistence of classical neurotransmitters and neuropeptides
The coexistence in the same neuron of classical neurotransmitters, like norepinephrine and acetylcholine, and w x neuropeptides has been demonstrated. Hokfelt . w x w x stance P 6 . Weihe and Reinecke 7 have also demonstrated in the sinoatrial node of different mammals, the presence of intrinsic neurons immunoreactive for VIP. Finally, it is worth mentioning that the sinoatrial node is also innervated by sensitive neurons containing various neuropeptides like substance P and calcitonin gene-related Ž . w x peptide CGRP 5 , as well as by extrinsic neurons conw x taining neurotensin 7 .
It has become clear that the autonomic nervous system is a much more complex system than previously thought. In fact, it seems capable, by integrating numerous neuropeptides, of a fine tuning in the control of cellular function and is not simply restricted to adrenergic or Ž . cholinergic transmission Fig. 1 .
Modulation of heart rate by peptides: Hypothetical mechanisms of action
Despite recent improvement in peptide characterization, and the demonstration of peptides and their receptors within cardiac tissue, the role played by neuropeptides in Interactions between these systems are likely and could certainly result in a fine control tuning of cardiac frequency. NE, norepinephrine; Ach, acetylcholine; INH., inhibition; q, increase and y, decrease in heart rate.
the autonomic nervous system is still poorly understood. The effects of neuropeptides are often considered as complex and raise many questions and hypotheses. Furthermore, it is difficult to evaluate their function for numerous w x Ž . reasons 8,9 : 1 the role of a neuropeptide is not universal, and can vary depending on its cellular or tissular Ž . localization; 2 within a particular tissue or organ, the function of a neuropeptide can change during ontogenic development. It cannot be excluded that the coexistence of many different neuropeptides is a paraphenomenon representing a consequence of evolution. It is thus possible that peptides have been important messengers in lower species, and that they have been replaced by more efficient smallw x Ž . molecules neurotransmitters 10 ; 3 characteristically, a neuropeptide has the property of interacting with other neuroactive substances. Consequently, its effect might only Ž . become evident when the interaction is revealed; 4 many actions of neuropeptides vary according to experimental Ž . conditions; 5 for several neuropeptides, no specific receptor agonists or antagonists are yet available, making interpretation of the observed effects more difficult. Finally, even if a biological parameter is modified by the administration of a peptide, it remains not easy to prove that this effect is functionally important in the normal physiology of the animal.
More specifically today, the modulation of heart rate by direct actions of endogenous peptides andror by their interactions with classical neurotransmitters still raises several questions. Nevertheless, it is possible, considering the anatomical and histological structures present in the sinoatrial node, to suggest various mechanisms which could explain the modulation by peptides of heart rate as well as of other cardiac parameters regulating cardiac function Ž . Fig. 2 .
Heart rate could be modulated by endocrine or paracrine actions of peptides originating from the vascular tissue. The vascular endothelium is a major site of production of various peptides. The coronary microvasculature possesses an endothelium which could release locally on demand certain peptides and thus, regulate heart rate by a direct w x action 11 . A second hypothesis would be a paracrine or even an autocrine modulation of heart rate by peptides coming from different cardiac tissues such as right atrial or Ž sinoatrial myocytes located in intracellular storage vesi-. cles , andror endocardial endothelium. Indeed, recent studies have shown that cardiac endothelial cells, regardless of their endocardial or coronary vascular origin, can directly modulate performance of the subjacent cardiomyw x ocytes 11 . The existence in human endocardial endothelium of a dense network of neurons containing various w x neuropeptides 12 is in favor of such a mechanism. Finally, the modulation of heart rate could be possible by the innervation of the sinoatrial node by neurons from the autonomic nervous system and by sensitive fibers allowing the local release of various neuropeptides. These neuropeptides could act directly on the sinoatrial node or interact with themselves andror with classical neurotransmitters to modulate heart rate. The principles of interaction between neuropeptides and classical neurotransmitters are similar, independent of whether the different substances are released from the same terminal, as in cotransmission, or from separate sources when, for example, two neurons w x converge on a single postsynaptic target 9 . In both cases, the interactions can be synergistic or antagonistic, and they may occur at the level of pre-and postsynaptic receptors as well as through altering the activity of degradative Ž . enzymes Fig. 3 . Depending on their origin and the conditions associated with their release or secretion, peptides could exert their actions on the sinoatrial node via specific receptors, could directly modulate the activity of various ion channels, pumps and transporters or could act as neuromodulators.
Examples of peptides modulating heart rate
Numerous peptides seem implicated in the modulation Ž . of the activity of the sinoatrial node Table 2 . The main ones are presented below.
Neuropeptide Y
Neuropeptide Y, consisting of 36 amino acids, was w x isolated from porcine brain by Tatemoto in 1982 13 . It is largely distributed in the sympathetic system and, among other sites, the peptide is colocalized with norepinephrine in synaptic terminals of postganglionic neurons innervating the cardiovascular system. Important concentrations of neuropeptide Y are found in the nodal tissue, the atria and w x the coronary vessels of rodent 14 , and a homogeneous distribution of sympathetic nerves containing neuropeptide Y has been shown in the conduction tissue of bovine heart w x 15 . Neuropeptide Y modulates sympathetic transmission Ž . in two ways: 1 it inhibits, presynaptically, the release of norepinephrine in response to sympathetic stimulation; and Table 2 Peptides possibly implicated in the modulation of heart rate via a direct Ž . chronotropic effect, and presence yes or not of specific receptors in the conduction tissue
Peptides
Heart
Positive chronotropic effect, q. Negative chronotropic effect, y. No direct effect but possible neuromodulation, 0. Not known, ?
Ž .
2 it potentiates postsynaptic effects induced by nor-Ž . epinephrine vasoconstriction, in particular . Specifically, it has been suggested that neuropeptide Y, released by sympathetic neuron terminals after intense stimulation, provokes a long inhibition of vagal tone. This effect would be secondary to activation of Y cardiac receptors. The 2 effects of neuropeptide Y on heart rate vary between species and the experimental models used. Thus, following its administration, an increase in heart rate is seen in isolated atrial preparations of guinea-pigs, a decrease is observed in isolated rat hearts, and no effects are reported in anaesthetized dogs. The presence of specific receptors for neuropeptide Y in the conduction tissue has not been demonstrated yet. On the other hand, Y receptor sub-types 3 w x have been identified in ventricular tissue of rat hearts 16 and it has been shown that neuropeptide Y has coronary w x vasoconstrictor effects in humans 17 .
VasoactiÕe intestinal peptide
Vasoactive intestinal peptide, composed of 28 amino acids, was first isolated in porcine small intestine. It possesses a potent vasodilatory activity when injected sysw x temically, justifying its name 18 . This peptide is usually colocalized in parasympathetic neurons, and it has been found in atrial postganglionic neuronal fibers, in coronary w x vessels and in great density in the sinoatrial node 5,19 . It is a coronary vasodilator which has potent positive chronotropic and inotropic effects in many species includw x ing humans 20,21 . Vasoactive intestinal peptide has been proposed as responsible for the phenomenon of 'excessive tachycardia' produced by vagal stimulation in presence of atropine and not blocked by the administration of a bw x adrenergic antagonist 22 . Receptors for VIP, coupled to adenylate-cyclase, have been found in atria and ventricles w x of human membranous preparations 23 .
Calcitonin gene-related peptide
Calcitonin gene-related peptide is a peptide of 37 amino acids present in sensitive neurons and often colocalized in the heart with tachykinins like substance P. Consistently, higher amounts of CGRP-immunoreactivity are found in the atria than in the ventricles. Within atria, CGRP-immunoreactivity is localized especially in sinoatrial and w x atrioventricular nodes 24 . Calcitonin gene-related peptide has positive chronotropic and inotropic properties in the great majority of species and in humans, but not in the dog where it would rather act as a neuromodulator without w x direct chronotropic effects 25 . Calcitonin gene-related peptide could interact with the parasympathetic system in the sinoatrial node by decreasing the negative chronotropic w x effect observed following vagal stimulation 26 . The density of binding sites for CGRP in the atria invariably exceeds that in the ventricles and some sites are also found w x on coronary arteries 25 .
Substance P
Substance P is a peptide which belongs to the tachykinin family. It is mainly found in sensitive fibers where it is w x usually colocalized with CGRP 8 . Nerves immunoreactive to substance P are detected in sinoatrial and atriovenw x tricular nodes of most mammals 5 and specific binding sites for substance P have been described in association w x with cardiac ganglions in guinea-pigs 27 . Substance P is a potent coronary vasodilator but most of the in vitro studies have shown that it does not exert direct effects on w x heart rate 28 . Nevertheless, considering its cardiac localization and colocalization with CGRP, substance P could play a modulatory role on sinoatrial function.
Angiotensin II
Angiotensin II is a circulating octapeptide which acts on various target organs after binding to membranous receptors. It plays a role, among others, in the regulation of blood pressure and circulating volume and in neuronal function. Beside the classical endocrine system, several other autocrine and paracrine systems exist, allowing angiotensin II to act locally on the organ and tissue which has released it. As early as 1987, the work from Saito et al. w x 29 has shown the presence, in great quantity, of angiotensin II converting enzyme at the level of the sinoatrial node artery, indicating the possibility of local synthesis of angiotensin II. The existence of a cardiac renin-angiotensin system is now well established. Angiotensin II allows the ( )release of catecholamines from cardiac sympathetic terminals and reduces vagal tone by a central action. It exerts positive chronotropic and inotropic effects in canine isow x lated atrial preparations 30 . Furthermore, angiotensin II injected directly into the sinoatrial node artery of anesthetized dogs, displays direct positive chronotropic effects w x 31 . These actions on heart rate are independent of the w x adrenergic system and are mediated via At receptors 32 . 1 These receptors have been localized by autoradiography in w x rat sinoatrial and atrioventricular nodes 33 .
Natriuretic peptides
The natriuretic peptide family is composed of three w x distinct peptides. In 1981, de Bold et al. 34 have reported that cardiac atria synthesize a vasodilatory and diuretic ( ) substance, the atrial natriuretic peptide ANP . This peptide is stored and released from secretory vesicles located in atrial cardiomyocytes as well as in sinoatrial and transiw x tional cells 35 . Contraction rate directly influences the w x secretion of ANP in rat isolated atria 36 . Furthermore, systemic hypotension following the administration of ANP w x is not accompanied by a reflex tachycardia 37 . To explain this phenomenon, three hypotheses have been proposed: Ž . 1 ANP decreases the activity of the sympathetic nervous w x Ž . system 38 ; 2 it potentiates the cardiac effects of the w x parasympathetic system 39 , by antagonizing cardiac a -1 w x Ž . adrenergic receptors 40 , and finally; 3 ANP has direct w x negative chronotropic effects 41 by regulating the activity w x of cardiac calcium channels 42 . A direct effect of ANP on the heart rate has, however, not been observed in the dog following its administration into the sinoatrial node w x artery 43 . Its effects on heart rate are therefore certainly the results of complex interactions. Indeed, a recent study in the rat has shown that clonidine stimulates the release of ANP by activating cardiac a -adrenergic and imidazoline 2 w x receptors 44 . Overall, ANP could act as a neuromodulator of heart rate.
( ) Brain natriuretic peptide BNP was discovered in 1988 w x in porcine brain 45 , but since then it has been shown to be mainly produced in cardiac ventricles. On the other hand, it is also found in atrial secretory granules and it is w x colocalized with ANP in ventricular conduction tissue 46 . At the present time, no one has studied the direct chronotropic effects of BNP.
( ) C-type natriuretic peptide CNP , the third member of w x the family, was discovered in 1990 47 . It is a neuropeptide which is also localized in the vascular endothelium and seems to play an important role in the regulation of vascular tone. Furthermore, it could have paracrine or w x autocrine actions in the heart 48 . C-type natriuretic peptide has positive chronotropic and inotropic effects, in in vitro and in vivo canine models, which appear related to an w x increase in the activity of calcium channels 43,49,50 .
Ž Genes coding for receptor of CNP the natriuretic peptide . receptor B; NPR-B are expressed in rat hearts and particuw x larly in the atria 51 . Furthermore, it has been observed that mRNA for this receptor is present in the dog at the w x level of the sinoatrial node and right atrium 49,50 .
Endothelins
The endothelin family is composed of endothelin 1, 2, and 3, and has biological actions in various tissues. These peptides have very potent vasoconstrictor properties and they modulate vascular tone. Endothelin 1, a peptide of 21 amino acids, was discovered in 1988 by Yanagisawa et al. w x 52 and it is produced by endothelial cells. Endothelin 1 has powerful positive chronotropic effects in guinea-pig w x isolated right atrial preparations 53 , as well as positive w x inotropic properties in the same animal model 54 . Still in the guinea-pig, endothelin 3 exerts a positive chronotropic effect at all the concentrations studied, whereas endothelin Ž 1 increases heart rate at weak concentrations 10 pmolrl to . 10 nmolrl and decreases heart frequency at high concen-Ž . trations 30 to 100 nmolrl . Endothelin 1, but not endothelin 3, reduces the rate of contraction of atria stimulated by Ž isoproterenol. Endothelin receptors A and B ET and 
Implications in disease states
Although theoretically neuropeptides can act as neurotransmitters or neuromodulators interfering with the sympathetic and parasympathetic systems to modulate heart rate, their pathophysiological involvement has not yet been proven during clinical studies looking at the cardiac conduction system. Nevertheless, it is highly conceivable in cardiac diseases such as cardiac arrhythmias, ischemic heart disease, congestive heart failure and hypertension, where the blood concentrations of several peptides are increased, that the 'peptidic pathway' plays an important role.
Increases in plasma concentrations of peptides might be related with beneficial antiarrhythmic or detrimental proarrhythmic effects. Atrial natriuretic peptide is released in great quantity during various tachyarrhythmias but its role w x in this context is still controversial. Crozier et al. 56 have suggested that ANP predisposes to atrial tachyarrhythmias w x whereas Takata et al. 57 have reported that it has cardioprotective effects during myocardial ischemia and prevents reperfusion arrhythmias. Moreover, it has been shown in numerous experimental studies that the activation of the cardiac renin-angiotensin system promotes arrhythmogenw x esis by several mechanisms 58 . The results of these animal studies complement the clinical observations of a decreased incidence of arrhythmias in cardiac insufficient patients treated with angiotensin converting enzyme inw x hibitors 59 . Endothelin, injected into the coronary circulation of anesthetized dogs, has been reported to lower the ( )w x threshold for ventricular fibrillation 60 . The myocardial production and release of endothelin-1 is stimulated in acute myocardial infarction and a pathological role for endothelin-1 in the development of ischemiarreperfusion w x injury is favored by some authors 61 . Finally, it has been demonstrated that the injection of various peptides such as angiotensin II, substance P, VIP and bradykinin, adjacent to spontaneously active in situ right atrial neurones of w x anesthetized dogs, resulted in ventricular arrhythmias 62 . Ž The plasma concentrations of several peptides ANP, . BNP, endothelin-1, neuropeptide Y, adrenomedullin have been reported to be increased in patients with congestive w x heart failure 8,62-64 . Natriuretic peptides and in particular BNP seem to be of increasing importance in the pathophysiology, diagnosis and prognosis of patients with w x congestive heart failure 65 . These circulating or local hormones participate in the myocardial, vascular and renal adaptations to the haemodynamic alterations of heart failure. Continued investigations into the role of these peptidic systems in the pathophysiology of evolving heart failure and in their interactions with the autonomic nervous system should be maintained. It would be interesting to know the role of peptidic modulation in such a condition where the sinoatrial node responsiveness to autonomic regulation appears to be largely impaired.
The potential role of peptidic modulation of heart rate may also be interesting to be revealed in hypertensive patients. Indeed, it has been reported that the plasma Ž concentrations of several peptides natriuretic peptides, . angiotensin II, neuropeptide Y, adrenomedullin are elevated with increasing severity of hypertension particularly w x where left ventricular hypertrophy is present 8,64,66 . The pathophysiological significance of these observations remains, however, to be further determined.
During cardiac transplantation, there is complete extrinsic denervation of the donor heart and although reinnervation may occur, it is usually only partial, and any functionally important reinnervation usually occurs late after transw x plantation 67,68 . Thus, the normal sympathetic and parasympathetic influences on the heart are absent, and studies of cardiac transplant recipients might provide an interesting model to assess the role of peptidic influence on heart rate. This avenue remains, however, to our knowledge almost unexplored. Supporting the interest of this w x unique model, Hunt et al. 69 have reported using embryonic rat heart grafted in oculo that changes in sympathetic innervation cause changes in the density of cardiac angiotensin II receptors. For the authors, these results might have implications for growth and function not only during cardiac development, but also during cardiac diseases.
Although the importance of the 'peptidic pathway' should not be overestimated, it nevertheless offers very exciting prospects. Thus, it is conceivable that the expression andror the abnormal control of some peptides contribute to a dis-equilibrium and could therefore affect cardiac function. The understanding of the various mechanisms involved and the planning of clinical research projects on the importance of peptides at the level of the conduction tissue, and more specifically on sinoatrial activity, may lead to the development of new pharmacological targets and novel therapeutic tools for the treatment of cardiac arrhythmias in man.
Conclusions
It seems very likely that heart rate is a biological function which is modulated by peptides. Different kinds of modulation could exist: an automodulation, a transneuronal modulation, a transsynaptic modulation, and finally a hormonal modulation. The variety of modulatory mechanisms involved most probably implies a hierarchy, interactions and a great complexity which are still poorly understood. 
